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a  b  s  t  r  a  c  t
Background:  Most  studies  investigating  the  role  of  personality  as a risk  factor for  the  development  of
opioid  dependence  compare  dependent  opioid  users  with  healthy  controls  who  never  used  heroin.  In
order  to  understand  the  potential  protective  role  of personality,  it  is crucial  to  compare  illicit  opioid
users  who  never  became  dependent  with  dependent  opioid  users.
Aims:  This  study  aims  to examine  the  role  of  personality  as  a risk  factor  for opioid  use  and  as  a  protective
factor  for  the  development  of  opioid  dependence.
Methods: Comparing  personality  factors  between  three  groups:  (1)  161  never-dependent  illicit  opioid
users  who  have  been  using  illicit opioids  but  never  became  opioid  dependent;  (2)  402  dependent  opioid
users  in methadone  maintenance  treatment  or  heroin-assisted  treatment;  and  (3)  135 healthy  controls
who  never  used  heroin.  Personality  was  assessed  with  a short  version  of Cloninger’s  Temperament  and
Character  Inventory.
Results: Never-dependent  opioid  users  reported  more  Novelty  Seeking  and  Harm  Avoidance  and  less
Self-Directedness  and  Cooperativeness  than  healthy  controls  and more  Reward  Dependence  and  Self-
Directedness,  and less  Harm  Avoidance  than dependent  opioid  users.  Furthermore,  never-dependent
opioid  users  reported  more  Self-Transcendence  than both  dependent  opioid  users  and healthy  controls.
Conclusions:  Never-dependent  opioid  users  may  have  started  to  use  opioids  partly  due  to their  tendency
to  seek  novel  and/or  spiritual  experiences  (high  Novelty  Seeking,  high  Self-Transcendence)  and  their
tendency  to avoid  aversive  stimuli  (high  Harm  Avoidance),  whereas  they may  have  been protected  against
the  development  of  dependence  by their  need  for social  approval  (high  Reward  Dependence)  and  their
self-efﬁcacy  (high  Self-Directedness).
© 2014  Elsevier  Ireland  Ltd.  All  rights  reserved.. IntroductionOpioid dependence is a worldwide health problem with severe
edical and social consequences (Degenhardt et al., 2013). In The
etherlands, the estimated number of problematic heroin users
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376-8716/© 2014 Elsevier Ireland Ltd. All rights reserved.amounts to 18,000 (National Drug Monitor Annual Report, 2011),
of which almost 13,000 (72%) are registered in addiction treat-
ment services: 60% in methadone and buprenorphine maintenance
treatment, 5% in heroin-assisted treatment (medical prescription of
diacetylmorphine), and 7% in abstinence oriented treatments. Most
of these interventions are proven effective and both morbidity and
mortality have been reduced resulting in an increasing life time
expectancy of opioid addicts in The Netherlands (van den Brink
and Haasen, 2006).
However, many more people have tried heroin and very little is
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eroin dependent. The current study attempts to ﬁll this gap with
pecial emphasis on the role of personality as a potential protective
actor for the development of opioid dependence in subjects with
 life-time history of self-exposure to illicit opioids.
Personality traits such as impulsivity have been associated
ith continued use, relapse, and unfavourable treatment outcomes
n several substance use disorders, including opioid dependence
Helmus et al., 2001), cocaine dependence (Broos et al., 2012;
oeller et al., 2001), and alcohol dependence (Meszaros et al., 1999;
vren et al., 2012; Bowden-Jones et al., 2005; Müller et al., 2008).
loninger’s Temperament and Character Inventory (TCI) has been
requently used in these studies and several of those studies have
hown that opioid dependent patients score signiﬁcantly higher on
ovelty Seeking (NS) than healthy controls (Milivojevic et al., 2012;
all, 1999; Fassino et al., 2004; Le Bon et al., 2004; Abbate-Daga
t al., 2007; Cohen et al., 2005). Novelty Seeking is also associated
ith an increased risk of early drug experimentation, which is con-
equently associated with an increased risk of dependence later
n life (Milivojevic et al., 2012). Opioid dependent patients also
core higher on Harm Avoidance (HA; Fassino et al., 2004; Le Bon
t al., 2004; Abbate-Daga et al., 2007; Cohen et al., 2005). Opioid
se may  function as a self-medication strategy to control anxiety
nd to overcome feelings of inadequacy (Abbate-Daga et al., 2007),
hich could explain the association between high anxiety person-
lity traits and opioid dependence. Lower Self-Directedness (SD) is
n element of an immature personality proﬁle, which is often found
n addicts (Fassino et al., 2004; Cohen et al., 2005). Self-Directedness
nd sometimes also Cooperativeness (C) and Reward Dependence
RD) were reported to be signiﬁcantly lower in opioid depend-
nt patients compared to healthy controls (Milivojevic et al., 2012;
assino et al., 2004; Le Bon et al., 2004). Higher Reward Depend-
nce is an indication of increased sensitivity to social approval and
ocial rewards (Le Bon et al., 2004), and low Reward Dependence
hus makes it is easier to use illegal drugs (Milivojevic et al., 2012).
owever, Fassino et al. (2004) found that Reward Dependence was
nly signiﬁcantly lower in heroin addicts when they also had a
ersonality disorder. Previous studies did not show a difference
n Persistence (P) between opioid dependent patients and healthy
ontrols. Finally, Korf et al. (2010) found that the never-dependent
pioid users in this study had a non-conventional life style and
ost of them were alternative or artistic, traits that are associated
ith high Self-Transcendence (ST). Finally, previous studies have
eported that opioid dependent people score signiﬁcantly higher on
elf-Transcendence than healthy controls (Milivojevic et al., 2012;
assino et al., 2004; Le Bon et al., 2004).
In most of these studies, opioid dependent patients were
ompared with healthy–opioid-naïve–controls or different opioid
ependent groups were compared with each other. Unfortunately,
here are no studies comparing the personality characteristics of
pioid dependent patients with those of illicit opioid users who
ever became dependent. Such data could be very important for a
etter insight in the risk factors and underlying processes responsi-
le for the development of heroin dependence and the prevention
nd early treatment of dependence.
Therefore, the aim of this study is to identify personality traits
ssociated with the development of illicit never-dependent opi-
id use and the protection against dependence in never-dependent
pioid users by comparing opioid users who never became opi-
id dependent (NDO), dependent opioid users (DO), and healthy
ontrols without any substance use disorder who never used illicit
pioids (HC).
Based on the above summary of the literature, and assuming
hat never-dependent opioid users have TCI scores between those
f dependent opioid users and healthy controls, we test the fol-
owing hypotheses: (1) never-dependent opioid users score lower
n Novelty Seeking and Harm Avoidance, and higher on Rewardependence 145 (2014) 101–105
Dependence, Self-Directedness and Cooperativeness compared to
dependent opioid users; (2) never-dependent opioid users score
higher on Novelty Seeking and Self-Transcendence compared to
healthy controls; (3) dependent opioid users score higher on Nov-
elty Seeking, Harm Avoidance and Self-Transcendence and lower
on Reward Dependence, Self-Directedness and Cooperativeness
compared to healthy controls, and there will be no difference on
Persistence between dependent opioid users and healthy controls.
2. Methods
This study is part of the ongoing research project “Opioid Receptors and Addic-
tion: a Genetic Approach.” The primary objective of the project is to determine risk
and  protective factors for the development of opioid dependence, including genetic
polymorphisms, family history of mental disorders and personality. This report con-
cerns the role of personality in the risk of never-dependent illicit opioid use and the
protection against the development of illicit opioid dependence.
2.1. Subjects
Three different samples were recruited, including a total of 698 participants
(Table 1):
2.2. Group 1. Never-dependent illicit opioid users (NDO)
Subjects in this group (N = 161) had to demonstrate a lifetime history of self-
exposure to illicit opioids, as indicated by at least ﬁve and a maximum of 100
opioid self-administrations. To minimise the possibility that these participants
would become opioid dependent after entering the study, ﬁrst opioid use should
have taken place at least 2 years before entering the study. These participants were
recruited through “convenience” sampling, like advertisements in local media, as
well as through “snowball” or “chain referral” sampling (Korf et al., 2010). About
one  third (32%) of these participants had taken illicit opioids 5–9 times, about half
(52.6%) had taken them 10–49 times, and the rest (16%) had taken illicit opioids
more frequently. The vast majority (87%) had experience with illicit heroin, more
than half (57%) with opium and 43% had used both substances (Korf et al., 2010).
Unfortunately we  have no information on the route of administration.
2.3. Group 2. Dependent opioid users in methadone maintenance or
heroin-assisted treatment (DO)
Subjects in this group (N = 402) had to be DSM-IV opioid dependent for at least
5  years. They were recruited from methadone maintenance programs (N = 200) and
heroin-assisted treatment programs (N = 202) in The Netherlands (van den Brink
et  al., 2003; Blanken et al., 2009, 2010). In the Netherlands, the route of administra-
tion  of street heroin is mainly (90–95%) through inhalation of heroin vapors (chasing
the dragon) and intravenous use occurs in only 5–10% of all subjects (National Drug
Monitor Annual Report, 2011). Similar heroin consumption patterns are seen in the
Dutch treatment settings, including methadone maintenance treatment and heroin
assisted treatment programs (Blanken et al., 2010; National Drug Monitor Annual
Report, 2011). These two  subgroups did not differ on any of the TCI-105 subscales
and were therefore treated as one group in all analyses.
2.4. Group 3. Healthy controls (HC)
Subjects in this group (N = 135) had no history of any illicit opioid use and
no  history of alcohol or drug (including cannabis) dependence (DSM-IV). Nicotine
dependence was  not an exclusion criterion. They were recruited in The Netherlands
through “convenience” sampling, like advertisements in local media, personal con-
tact, or referral by others.
All participants had to be at least 25 years of age.
The study was  approved by the Central Committee on Research Involving Human
Subjects (CCMO) in the Netherlands (protocol number P04.0156C) and all partici-
pants gave written informed consent.
2.5. Assessment
Socio-demographic characteristics: Information about age, gender, country of
origin, education and marital status was collected using a standard questionnaire.
Ethnicity was operationalized as follows: a subject was considered Caucasian when
both parents originated from a European country or the USA and non-Caucasian
otherwise. The latter group comprised mainly of subjects with parents from Asian
countries, Surinam, Middle Eastern or Hispanic countries.Diagnosis: The SUD section of the computerized fully structured Composite
International Diagnostic Interview (CIDI Auto 2.0; Kessler and Wittchen, 1998) was
used to obtain DSM-IV substance dependence diagnoses. The CIDI can be used
by  non-clinicians and has good reliability and validity when compared to semi-
structured interviews such as the AUDADIS and the SCAN (Ustün et al., 1997).
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Table  1
Socio-demographic and opioid use characteristics in never-dependent opioid users (NDO), dependent opioid users (DO) and healthy controls (HC).
NDO DO HC P
N  161 402 135
Mean age (SD) 39.3 (8.6) 44.7 (6.9) 40.8 (9.9) <0.001
Male  69.6% 77.9% 52.6% <0.001
Caucasian 84.5% 72.9% 88.1% <0.001
Medium secondary school or higher 92.5% 53.0% 95.6% <0.001
Married or cohabiting 25.5% 15.4% 64.4% <0.001
Age  ﬁrst opioid use (mean + SD) 21.8 (5.6) 20.2 (5.6) – 0.002
Duration of opioid use >1year 44.0% 96.1% – <0.001
Eleven respondents had missing values for ‘Age ﬁrst opioid use’ (11 DO) and 15 respondents had missing values for ‘Duration of opioid use >1 year’ (2 NDO, 13 DO).
Table  2
TCI-105 scores of never-dependent opioid users (NDO), dependent opioid users (DO) and healthy controls (HC), ANCOVAs and post hoc tests.
NDO DO HC F (2, 691) P Pairwise comparisons between groups
N  161 402 135
Novelty Seeking 8.6 (3.0) 7.8 (2.7) 7.3 (2.9) 7.4 <0.001 NDO > HC
Harm Avoidance 5.6 (3.7) 7.7 (3.8) 4.1 (3.3) 49.1 <0.001 DO > NDO > HC
Reward Dependence 9.4 (2.8) 8.2 (2.7) 9.7 (2.6) 13.1 <0.001 HC, NDO > DO
Persistence 8.3 (3.4) 7.8 (3.0) 8.6 (2.5) 4.4 0.013
Self-Directedness 11.5 (3.2) 9.3 (3.6) 13.8 (1.9) 70.1 <0.001 HC > NDO > DO
Cooperativeness 12.4 (2.6) 11.5 (2.7) 13.9 (1.4) 28.7 <0.001 HC > NDO, DO



































Never-dependent opioid users vs. dependent opioid users: Com-
pared to dependent opioid users, never-dependent opioid users
scored signiﬁcantly lower on Harm Avoidance (conform hypothe-
sis) and higher on Reward Dependence and Self-Directedness (both
Table 3
Standardized effect sizes (Cohen’s d) for signiﬁcant (p < 0.0024) differences in TCI-
105 scores between never-dependent opioid users (NDO), dependent opioid users
(DO) and healthy controls (HC).
NDO/DO NDO/HC DO/HC
Novelty Seeking NS 0.42 NS
Harm Avoidance −0.58 0.49 1.07
Reward Dependence 0.42 NS −0.51eans represent raw data that were not adjusted for gender, education, ethnicity a
eventy of the 698 subjects (13 NDO, 47 DO, 10 HC) had missing items on the TCI-10
Personality and personality disorder: Cloninger’s Temperament and Character
nventory (TCI; Cloninger et al., 1993) was used as the main personality question-
aire in the study. The TCI is a self-report, yes-or-no type questionnaire, designed
o  quantify individual differences on four temperament and three character dimen-
ions. A validated Dutch translation of the TCI is available, including a shortened
ersion (TCI-105), in which the original 240 items are reduced to 105 items with
5  items per scale. With the TCI-105, all seven dimensions of the TCI are measured:
ovelty Seeking (NS), Harm Avoidance (HA), Reward Dependence (RD), Persistence
P),  Self-Directedness (SD), Cooperativeness (C) and Self-Transcendence (ST).
.6. Statistical analyses
Single imputation (mean imputation) was  used for missing items on the TCI.
his  was  performed for each scale by replacing the missing value with the mean
core of the non-missing items of the person for the speciﬁc scale.
To determine whether groups signiﬁcantly differed on socio-demographic char-
cteristics, one-way ANOVA and Chi-square tests were used for continuous and
ategorical variables, respectively.
A  MANCOVA was performed with the seven scales as dependent variables, group
s an independent factor, gender, education (‘medium secondary school or higher’)
nd ethnicity (‘Caucasian’) as co-factors and age as a covariate. All covariates fulﬁlled
he parallel slope assumption. When the multivariate test was signiﬁcant, univari-
te ANCOVAs were used to determine which scales signiﬁcantly differed between
roups. Post-hoc tests were used to compare the groups for each dependent vari-
ble  where ANCOVAs showed signiﬁcant group differences. To adjust for multiple
esting, statistical signiﬁcance was deﬁned as p < 0.0024 (Bonferroni correction for
hree groups and seven TCI scales:  ˛ = 0.05/21 = 0.0024).
All statistical analyses were performed using IBM Statistical Package for the
ocial Sciences (SPSS) version 20.
. Results
.1. Sample characteristics
Socio-demographic characteristics and opioid use of the three
roups are presented in Table 1. The groups differed signiﬁcantly
n several socio-demographic and opioid use characteristics. The
O group was older, contained more males and less Caucasians and
 lower level of education compared to the NDO and the HC groups.
he percentage of married and cohabiting persons was  higher in the
C group than in the NDO and DO groups. In addition, we found a
mall but signiﬁcant difference in the age of onset of ﬁrst opioid
se between the DO and the NDO groups.e (SD).
 items), but none of the participants missed four or more questions from one scale.
3.2. Temperament and character inventory
Internal consistency of the TCI-105 subscales was very similar
for all three groups and generally good to excellent with Cronbach’s
 ˛ ranging from 0.533 for Cooperativeness in the HC group to 0.895
for Self-Transcendence in the NDO group. The TCI-105 scores of the
HC group fell within the norm scores of the Dutch population (data
not presented).
In the MANOVA, we  found a signiﬁcant multivariate effect of
group on the TCI-105 scales, Pillai’s Trace, V = 0.4, F (14, 1382) = 24.7,
p = < 0.001. The seven ANCOVA’s showed no signiﬁcant group by
sex, group by education, group by age and group by ethnicity inter-
actions on the TCI-105 scales. Results of univariate ANCOVAs and
post hoc tests are given in Tables 2 and 3. Within the NDO group
there were participants with (N = 99) and without (N = 65) a life-
time DSM-IV substance use disorder diagnosis other than opioid
dependence. However, these two subgroups did not differ on any
of the TCI-105 subscales, and therefore the NDO-group was treated
as one group in all analyses.
3.3. Group comparisonsPersistence NS NS NS
Self-Directedness 0.55 −0.86 −1.30
Cooperativeness NS −0.65 −0.86
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onform hypotheses) and Self-Transcendence. No signiﬁcant differ-
nces in Novelty Seeking (not conform hypothesis) and Persistence
cores were found between these groups (Table 3).
Never-dependent opioid users vs. healthy controls: Com-
ared to healthy controls, never-dependent opioid users scored
igniﬁcantly higher on Novelty Seeking, Harm Avoidance and Self-
ranscendence (all three conform hypothesis) and signiﬁcantly
ower on Self-Directedness and Cooperativeness. No signiﬁcant dif-
erences in Reward Dependence and Persistence scores were found
etween these groups (Table 3).
Dependent opioid users vs. healthy controls: Compared to
ealthy controls, dependent opioid users scored signiﬁcantly
igher on Harm Avoidance and Self-Transcendence (both conform
ypotheses) and signiﬁcantly lower on Reward Dependence, Self-
irectedness and Cooperativeness (all three conform hypotheses).
o signiﬁcant Novelty Seeking scores were found between these
roups (not conform hypothesis; Table 3).
. Discussion
The present study compared personality factors in three groups:
llicit opioid users who never became dependent, opioid dependent
atients in methadone maintenance or heroin-assisted treatment
nd healthy controls who never used illicit opioids.
Conﬁrming most of our hypotheses, never-dependent opioid
sers reported more Novelty Seeking and Harm Avoidance and
ess Self-Directedness and Cooperativeness than healthy controls
nd more Reward Dependence and Self-Directedness, and less
arm Avoidance than dependent opioid users. Furthermore, never-
ependent opioid users reported more Self-Transcendence than
oth dependent opioid users and healthy controls.
The higher level of Reward Dependence in never-dependent
ompared to dependent illicit opioid users means that never-
ependent illicit opioid users were more sensitive to social
pproval (Le Bon et al., 2004) and this may  have protected them
gainst developing dependence. In contrast, persons with low
eward Dependence who experiment with illegal use may  be
ess inﬂuenced by the social disapproval of their illegal drug use
Milivojevic et al., 2012). In addition, the higher level of Self-
irectedness in never-dependent illicit opioid users may  have
elped them to better adapt and regulate their behavior to ﬁt
he situation in agreement with individually chosen goals and
alues and may  thus have protected them from developing uncon-
rolled drug use behaviors and opioid dependence (Le Bon et al.,
004). In contrast, low Self-Directedness is an element of an imma-
ure personality proﬁle, which is often found in addicted people.
herefore, higher scores on scales for Reward Dependence and
elf-Directedness may  have protected the never-dependent illicit
pioid users from losing control and becoming addicted. The higher
elf-Transcendence levels in never-dependent illicit opioid users
ompared to the other two groups suggests that they were sus-
eptible to fantasy and daydreaming, and this is enhanced by
he use of opioids (Milivojevic et al., 2012). Therefore, high Self-
ranscendence in never-dependent illicit opioid users may  have
een involved in the choice to experiment with opioids. Further-
ore, the high level of Harm Avoidance in never-dependent illicit
pioid users may  be related to their use of opioids in order to con-
rol anxiety and to overcome feelings of inadequacy as is indicated
y the fact that the highest Harm Avoidance scores were found
n the dependent opioid users, somewhat lower Harm Avoidance
cores in the never-dependent illicit opioid users, and the low-
st Harm Avoidance scores in the healthy controls. In contrast to
ur hypothesis, never-dependent illicit opioid users had similar
ovelty Seeking scores compared to dependent opioid users, but
onsistent with our expectations, never-dependent opioid usersependence 145 (2014) 101–105
had signiﬁcantly higher Novelty Seeking scores than healthy con-
trols. These ﬁndings suggest that Novelty Seeking is a risk factor
to start using illicit opioids but not a speciﬁc risk factor to develop
opioid dependence.
Unexpectedly, Novelty Seeking was  not very high in the depend-
ent opioid users, although this has been found in several previous
studies (Milivojevic et al., 2012; Ball, 1999; Fassino et al., 2004; Le
Bon et al., 2004; Abbate-Daga et al., 2007; Cohen et al., 2005). How-
ever, the dependent opioid users were addicted for a much longer
period and were older than those in most of the previous studies
(Milivojevic et al., 2012; Fassino et al., 2004; Le Bon et al., 2004;
Abbate-Daga et al., 2007). This may  explain the difference between
the present ﬁnding and earlier studies.
Lower Self-Directedness and Cooperativeness and higher Self-
Transcendence compared to healthy controls was found in both
dependent opioid users and never-dependent opioid users, indi-
cating the presence of an immature or frail personality (Fassino
et al., 2004) in illicit opioid users. Consistent with earlier studies, we
found that dependent opioid users scored signiﬁcantly higher on
Harm Avoidance and Self-Transcendence and signiﬁcant lower on
Reward Dependence, Self-Directedness and Cooperativeness than
healthy controls (Milivojevic et al., 2012; Fassino et al., 2004; Le Bon
et al., 2004; Abbate-Daga et al., 2007; Cohen et al., 2005). From these
results we  can conclude that the opioid dependent and healthy con-
trol samples are congruent with samples in previous studies and
that differences between never-dependent illicit opioid users and
dependent opioid users and healthy controls cannot be attributed
to sample speciﬁcity.
Besides several study strengths, such as the relatively large
study groups and the inclusion of never-dependent life-time illicit
opioid users, some study limitations need to be considered. First,
this is a retrospective study, and it is, therefore, not possible to
determine whether differences in personality traits are a cause or
a consequence of drug use and dependence. A second limitation is
that there is still a chance that some of the never-dependent opi-
oid users did become dependent after participation in the study.
To minimize this risk, ﬁrst opioid use had to occur at least 2 years
before the start of the study – in order to include subjects that had
not become dependent in the ﬁrst 2 years after using illicit opioids
– and a maximum lifetime opioid use of 100 times was  set. Thirdly,
not all character dimensions remain stable during life. Personality
traits are susceptible to change over time (Gourion et al., 2003), in
particular Novelty Seeking, Self-Directedness and Cooperativeness
(Duijsens et al., 2000). The groups differed in age, but all group com-
parisons were adjusted for age. Finally, gender inﬂuences the risk
of drug use, with men  being more likely to use drugs than women
(Lynch et al., 2002). Moreover, some studies have found that opi-
oid drug use in women tends to escalate more rapidly than in men
(Becker and Hu, 2008). In the present study, the group of never-
dependent opioid users contained more females than the groups
of dependent opioid users. However, all group comparisons were
adjusted for gender.
The current ﬁndings are important for the planning of preven-
tion strategies, because TCI personality proﬁles can be used in the
screening of youngsters in order identify those adolescents with an
increased risk for illicit opioid use and dependence, and for a per-
sonalized intervention based on their personality proﬁle (Conrod
et al., 2013, 2010).
In summary, never-dependent illicit heroin users may have
started to use heroin partly due to their tendency to seek novel
and/or spiritual experiences (high Novelty Seeking, high Self-
Transcendence) and their tendency to avoid aversive stimuli (high
Harm Avoidance), whereas they may  have been protected against
the development of dependence by their need for social approval
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